Study questions link between antidepressants, miscarriage

September 9, 2014 by Amy Norton, Healthday Reporter

Study questions link between antidepressants, miscarriage
Depression, rather than SSRIs, might fuel the association, researchers suggest.
(HealthDay)—Some studies have found that women who use common antidepressants early in pregnancy face a raised risk of miscarriage, but new research suggests the link might be better explained by the depression, rather than the drugs that treat it.

Looking at records for more than 1.2 million , researchers found that those prescribed selective serotonin reuptake inhibitors (SSRIs) in their first trimester were 27 percent more likely to have a miscarriage than who weren't on the drugs.

But a similar increase was also found among women who'd stopped using an SSRI three months to a year before becoming pregnant.

That suggests some other factor—possibly the depression itself—might explain the miscarriage link, the researchers suggested.

"We believe that these results clearly indicate that miscarriage is not associated with SSRIs, but with conditions associated with the use of SSRIs," said lead researcher Dr. Jon Andersen, of Copenhagen University Hospital in Denmark.

Not everyone was convinced, though.

Dr. Adam Urato, a maternal-fetal medicine specialist at Tufts Medical Center in Boston, has studied the issue. He said the new research has limitations, including its reliance on prescription records because it's impossible to know whether women actually took their medications.

"This kind of misclassification will bias the results toward the null, which just means that it makes the study more likely to say that the drugs are safe when they aren't," Urato said.

More important, Urato said, the findings should be seen in the wider context. A number of studies have linked SSRIs during pregnancy to a heightened risk of miscarriage, preterm birth, pregnancy complications such as pre-eclampsia, and developmental disorders such as autism later in a child's life.

Those types of studies do not prove cause-and-effect. But Urato said there's some biological evidence to back up a link: Animal research has shown that SSRI exposure during pregnancy can cause the same types of problems that have turned up in some human studies.

Plus, "we know that the serotonin system is crucial for the developing fetus. And SSRIs disrupt that system," Urato said.

Serotonin is a chemical "messenger" that helps regulate mood, appetite, blood vessel dilation and other vital functions. SSRIs, which raise , have become the "first-line" drug against depression, and include drugs such as fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa) and paroxetine (Paxil).

Andersen said one of the difficulties in studying whether SSRIs contribute to miscarriage is that it's hard to know whether any negative effect is the result of the drugs, the underlying depression, or some other factor.

He added he believes that his study helps address that problem by including women who were recently on SSRIs, but stopped before becoming pregnant.

The findings, reported in the October issue of Obstetrics & Gynecology, are based on records for more than 1.2 million Danish women who were pregnant between 1997 and 2010.

Of nearly 23,000 women who had a prescription for an SSRI in the first 35 days of pregnancy, 12.6 percent had a miscarriage. That compared with just over 11 percent of women with no SSRI prescription.

When Andersen's team considered factors such as maternal age and income, SSRI use was still tied to a 27 percent increase in miscarriage risk. But there was a similar increase among women who'd stopped an SSRI prescription at least three months before pregnancy.

Andersen pointed to possible explanations for the risks. "Other studies have shown that people suffering from depression are more likely to abuse alcohol and smoke," he said, "and it is possible that women [with] depression are less likely to follow the recommendation of folic acid supplementation before and during pregnancy."

The researchers' conclusions are "reasonable," said Christina Chambers, director of the Center for the Promotion of Maternal Health and Infant Development at the University of California, San Diego.

And while other studies have tied SSRIs to pregnancy risks, those excess risks have been "modest," Chambers noted.

"If there are risks, they seem to be fairly small," she said.

So for any one woman, those potential risks would have to be weighed against the risks of stopping an SSRI, particularly for women with more severe , Chambers said.

Urato agreed that for some women, taking an SSRI during might be the right move. "Am I saying no one should take these drugs? No," he said.

But, Urato added, women should be told what the evidence is, so they can make an informed decision about whether to stick with their medication.

Explore further: Antidepressant use during pregnancy not linked to autism

More information: The Organization of Teratology Information Specialists has more on medication safety during pregnancy.

Abstract
Full Text (subscription or payment may be required)

Related Stories

Antidepressant use during pregnancy not linked to autism

December 19, 2013
(HealthDay)—Despite some concerns to the contrary, children whose moms used antidepressants during pregnancy do not appear to be at increased risk of autism, a large new Danish study suggests.

Antidepressants in pregnancy won't harm baby's heart, study suggests

June 18, 2014
(HealthDay)—Antidepressants taken during the first three months of pregnancy don't appear to increase the risk of heart defects in babies, new research suggests.

Risk of transient breathing difficulties in newborns of mothers on antidepressants

January 14, 2014
Infants of expectant mothers who take antidepressant drugs, known as selective serotonin reuptake inhibitors (SSRIs), during late pregnancy are at an increased risk for persistent pulmonary hypertension (high blood pressure ...

In utero exposure to antidepressants may influence autism risk

June 3, 2014
(Medical Xpress)—A new study from researchers at Drexel University adds evidence that using common antidepressant medications during pregnancy may contribute to a higher risk of autism spectrum disorders (ASD) in children, ...

Antidepressant use in pregnancy may be associated with structural changes in the infant brain

May 20, 2014
(Medical Xpress)—A new study by University of North Carolina at Chapel Hill researchers found that children of depressed mothers treated with a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs) ...

Study ties antidepressant use in pregnancy to autism risk in boys

April 14, 2014
(HealthDay)—Boys with autism were three times more likely to have been exposed to antidepressants known as SSRIs in the womb than typically developing children, according to new research.

Recommended for you

Human Cell Atlas study reveals maternal immune system modifications in early pregnancy

November 14, 2018
The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta. Researchers from the Wellcome Sanger Institute, Newcastle ...

Soy formula feeding during infancy associated with severe menstrual pain in adulthood

November 9, 2018
New research suggests that infant girls fed soy formula are more likely to develop severe menstrual pain as young adults. The finding adds to the growing body of literature that suggests exposure to soy formula during early ...

A major role for a small organ in the immune response during pregnancy

November 9, 2018
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden. This study, published in the Journal of Allergy ...

Mailed HPV tests can help find women at-risk for cervical cancer, study finds

November 7, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer ...

Women who give birth to boys much more likely to have postnatal depression

November 6, 2018
A University of Kent study into postnatal depression (PND) found the odds of developing this condition increased by 79% when mothers had baby boys compared to baby girls.

New study takes first step toward treating endometriosis

November 1, 2018
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.